John Moriarty's most recent trade in Avidity Biosciences Inc was a trade of 160,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 27, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Avidity Biosciences Inc | John B. Moriarty | Chief Legal Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Feb 2026 | 160,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | John B. Moriarty | Chief Legal Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Feb 2026 | 92,054 | 0 | - | - | Common Stock | |
| Avidity Biosciences Inc | John B. Moriarty | Chief Legal Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Feb 2026 | 50,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | John B. Moriarty | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 72.23 per share. | 07 Jan 2026 | 2,374 | 74,557 | - | 72.2 | 171,474 | Common Stock |
| Avidity Biosciences Inc | John B. Moriarty | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 56,000 | 103,755 | - | 0 | Common Stock | |
| Avidity Biosciences Inc | John B. Moriarty | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.87 per share. | 17 Dec 2025 | 26,824 | 76,931 | - | 71.9 | 1,927,841 | Common Stock |
| Avidity Biosciences Inc | John B. Moriarty | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 36.21 per share. | 04 Aug 2025 | 2,245 | 47,755 | - | 36.2 | 81,291 | Common Stock |
| Avidity Biosciences Inc | John Moriarty B. | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Moriarty B. John | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 25,000 | 50,000 | - | 0 | Common Stock | |
| LendingTree Inc | John David Moriarty | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2023 | 3,678 | 13,238 (0%) | 0% | - | Common Stock | |
| LendingTree Inc | John David Moriarty | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2023 | 3,678 | 7,358 | - | - | Restricted Stock Units | |
| LendingTree Inc | John David Moriarty | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2023 | 1,993 | 0 | - | - | Restricted Stock Units | |
| LendingTree Inc | John David Moriarty | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2023 | 1,993 | 10,654 (0%) | 0% | - | Common Stock | |
| LendingTree Inc | John David Moriarty | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.08 per share. | 02 Mar 2023 | 1,895 | 11,343 (0%) | 0% | 33.1 | 62,687 | Common Stock |
| LendingTree Inc | John David Moriarty | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2023 | 1,776 | 1,777 | - | - | Restricted Stock Units | |
| LendingTree Inc | John David Moriarty | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2023 | 1,776 | 13,119 (0%) | 0% | - | Common Stock | |
| LendingTree Inc | John David Moriarty | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.08 per share. | 02 Mar 2023 | 1,094 | 9,560 (0%) | 0% | 33.1 | 36,190 | Common Stock |
| LendingTree Inc | John David Moriarty | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.00 per share. | 02 Mar 2023 | 910 | 12,209 (0%) | 0% | 33 | 30,030 | Common Stock |
| LendingTree Inc | John David Moriarty | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 22,000 | 22,000 | - | - | Restricted Stock Units | |
| LendingTree Inc | John David Moriarty | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2023 | 968 | 9,213 (0%) | 0% | - | Common Stock | |
| LendingTree Inc | John David Moriarty | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2023 | 968 | 0 | - | - | Restricted Stock Units | |
| LendingTree Inc | John David Moriarty | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.20 per share. | 28 Feb 2023 | 552 | 8,661 (0%) | 0% | 32.2 | 17,774 | Common Stock |
| Olema Pharma Inc | John B. Moriarty | EVP, Ch. Legal Officer & Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Olema Pharma Inc | John B. Moriarty | EVP, CH. LEGAL OFFICER & SEC. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 166,250 | 166,250 | - | - | Stock Option (Right to Buy) |